Hemenway Trust Hemenway Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-5,423
Closed -$356K 156
2015
Q4
$356K Hold
5,423
0.09% 110
2015
Q3
$306K Sell
5,423
-1,061
-16% -$68.8K 0.08% 124
2015
Q2
$383K Hold
6,484
0.1% 123
2015
Q1
$404K Sell
6,484
-533
-8% -$31K 0.11% 116
2014
Q4
$404K Buy
7,017
+604
+9% +$33.7K 0.12% 93
2014
Q3
$345K Sell
6,413
-350
-5% -$18.5K 0.11% 103
2014
Q2
$355K Buy
+6,763
New +$346K 0.11% 105
2013
Q4
Sell
-7,749
Closed -$293K 183
2013
Q3
$293K Sell
7,749
-61,879
-89% -$2.41M 0.11% 98
2013
Q2
$2.73M Buy
+69,628
New +$2.71M 1.16% 38

Other funds holding TEVA

Hemenway Trust Hemenway Trust's TEVA Position: Q1 2016 in Review

Hemenway Trust Hemenway Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2016, closing a stake of 5,423 shares — an estimated $356K sold.

Hemenway Trust Hemenway Trust first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $2.73M in Q2 2013. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

  • Hemenway Trust Hemenway Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2016 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 5,423 Teva Pharmaceutical Industries Limited shares in Q1 2016, an estimated $356K.
  • Hemenway Trust Hemenway Trust first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 9 quarters.
  • Hemenway Trust Hemenway Trust's Teva Pharmaceutical Industries Limited position peaked at $2.73M in Q2 2013.
  • 837 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2016.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2016, filed 27 May 2016.